Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium
- PMID: 8445368
- DOI: 10.1099/0022-1317-74-3-453
Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium
Abstract
The attachment protein, G, of human respiratory syncytial virus (RSV) is an M(r) 84K to 90K species which has a high content of N-linked and O-linked carbohydrates. The unglycosylated form of this protein was expressed by inserting a full-length cDNA copy of the mRNA from the A2 strain of RSV into a prokaryotic expression vector under the control of the lambda PL promoter. Salmonella typhimurium cells transformed with the G-containing plasmid synthesized a protein of M(r) 40,000 that specifically reacted with polyclonal and two neutralizing monoclonal antibodies raised against the native RSV G glycoprotein. Recombinant G protein was purified by immunoaffinity chromatography using a neutralizing monoclonal antibody. Cotton rats immunized with the recombinant G protein produced serum antibodies to the G glycoprotein that neutralized RSV in vitro. The study demonstrates that the G protein of RSV can be expressed in bacteria and that at least one neutralizing epitope is not structurally dependent on carbohydrates.
Similar articles
-
Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.J Gen Virol. 1993 Sep;74 ( Pt 9):1995-9. doi: 10.1099/0022-1317-74-9-1995. J Gen Virol. 1993. PMID: 8397289
-
Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.Virology. 2000 Mar 30;269(1):54-65. doi: 10.1006/viro.2000.0186. Virology. 2000. PMID: 10725198
-
Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.J Immunol. 1998 Sep 1;161(5):2473-80. J Immunol. 1998. PMID: 9725246
-
Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.J Gen Virol. 1993 Dec;74 ( Pt 12):2559-65. doi: 10.1099/0022-1317-74-12-2559. J Gen Virol. 1993. PMID: 7506297
-
Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.J Gen Virol. 1997 Oct;78 ( Pt 10):2411-8. doi: 10.1099/0022-1317-78-10-2411. J Gen Virol. 1997. PMID: 9349459 Review. No abstract available.
Cited by
-
Structural Characterization and Binding Studies of the Ectodomain G Protein of Respiratory Syncytial Virus Reveal the Crucial Role of pH with Possible Implications in Host-Pathogen Interactions.ACS Omega. 2021 Apr 7;6(15):10403-10414. doi: 10.1021/acsomega.1c00800. eCollection 2021 Apr 20. ACS Omega. 2021. PMID: 34056193 Free PMC article.
-
Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens.J Clin Microbiol. 1997 Feb;35(2):354-7. doi: 10.1128/jcm.35.2.354-357.1997. J Clin Microbiol. 1997. PMID: 9003595 Free PMC article.
-
Protein glycosylation in infectious disease pathobiology and treatment.Cent Eur J Biol. 2011;6(5):802. doi: 10.2478/s11535-011-0050-8. Epub 2011 Aug 10. Cent Eur J Biol. 2011. PMID: 32215117 Free PMC article. Review.
-
Respiratory syncytial virus vaccines.Clin Microbiol Rev. 1998 Jul;11(3):430-9. doi: 10.1128/CMR.11.3.430. Clin Microbiol Rev. 1998. PMID: 9665976 Free PMC article. Review.
-
Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro.J Virol. 1998 Sep;72(9):7221-7. doi: 10.1128/JVI.72.9.7221-7227.1998. J Virol. 1998. PMID: 9696816 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources